ArticleJournal of ovarian research2014

Sequential combination therapy with flavopiridol and autocatalytic caspase-3 driven by amplified hTERT promoter synergistically suppresses human ovarian carcinoma growth in vitro and in mice.

Yue Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.